期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 25, 期 2, 页码 784-800出版社
WILEY
DOI: 10.1111/jcmm.16132
关键词
APE1/Ref-1; Cancer-associated fibroblasts; Napabucasin; Pancreatic cancer; Ruxolitinib; STAT3; tumor microenvironment
资金
- DOD Neurofibromatosis Research Program [W81XWH-19-1-0217]
- IUSCC Cancer Center Support grant [P30 CA082709]
- National Institute of Health and National Cancer Institute [R01CA167291, R01CA167291-S1]
- NIH/NCI [R01CA138798, U01HL143403, R01CA211098, R01NF180045]
- Riley Children's Foundation
- Tom Wood Lexus Foundation
This study investigates the synergistic effect of dual targeting Ref-1 and STAT3 pathways in cancer, showing promising results in inhibiting tumor growth and improving tumor response by hindering crosstalk between tumor and its microenvironment.
With a plethora of molecularly targeted agents under investigation in cancer, a clear need exists to understand which pathways can be targeted simultaneously with multiple agents to elicit a maximal killing effect on the tumour. Combination therapy provides the most promise in difficult to treat cancers such as pancreatic. Ref-1 is a multifunctional protein with a role in redox signalling that activates transcription factors such as NF-kappa B, AP-1, HIF-1 alpha and STAT3. Formerly, we have demonstrated that dual targeting of Ref-1 (redox factor-1) and STAT3 is synergistic and decreases cell viability in pancreatic cancer cells. Data presented here extensively expands upon this work and provides further insights into the relationship of STAT3 and Ref-1 in multiple cancer types. Using targeted small molecule inhibitors, Ref-1 redox signalling was blocked along with STAT3 activation, and tumour growth evaluated in the presence and absence of the relevant tumour microenvironment. Our study utilized qPCR, cytotoxicity and in vivo analysis of tumour and cancer-associated fibroblasts (CAF) response to determine the synergy of Ref-1 and STAT3 inhibitors. Overall, pancreatic tumours grown in the presence of CAFs were sensitized to the combination of STAT3 and Ref-1 inhibition in vivo. In vitro bladder and pancreatic cancer demonstrated the most synergistic responses. By disabling both of these important pathways, this combination therapy has the capacity to hinder crosstalk between the tumour and its microenvironment, leading to improved tumour response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据